Is EDIT a good investment?
As of 2025-03-15, the Fair Value of Editas Medicine Inc (EDIT) is -12.69 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.37 USD, the upside of Editas Medicine Inc is -1,026.14%. This means that EDIT is not a good investment.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -133.75 | -115.98 | -192.50 | -220.43 | -153.22 | -163.18 |
| YoY growth | -21.65% | 13.29% | -65.98% | -14.51% | 30.49% | -11.67% |
| Market Cap (mil) | 113.68 |
| P/E | |
| Forward P/E |
| EPS | -2.54 |
| Avg earnings growth rate | -11.67% |
| TTM earnings | -210.57 |